Upfront Stem Cell Transplant Remains Standard of Care for Newly Diagnosed Multiple Myeloma Upfront Stem Cell Transplant Remains Standard of Care for Newly Diagnosed Multiple Myeloma
Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news
More News: Allergy | Allergy & Immunology | Cancer & Oncology | Hematology | Myeloma | Stem Cell Therapy | Stem Cells | Transplants